U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07401316) titled 'Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors' on Feb. 03.
Brief Summary: This study will evaluate the utility of ctDNA detection in patients with high-risk stage I, stage II, and stage III germ cell tumor disease to develop a tool for post-treatment cancer cell detection.
Study Start Date: March, 2026
Study Type: OBSERVATIONAL
Condition:
Germ Cell Cancer Metastatic
Intervention:
DIAGNOSTIC_TEST: Whole blood for ctDNA
Whole blood for ctDNA
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Indiana University
Information provided by (Responsible Party): Nabil Adra, Indiana University
Published by HT Digital C...